Unlock stock picks and a broker-level newsfeed that powers Wall Street.
25.21
+0.20
+(0.80%)
At close: March 28 at 4:00:02 PM EDT
25.13
-0.08
(-0.34%)
After hours: March 28 at 7:59:48 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 13 | 13 | 21 | 20 |
| Avg. Estimate | 0.72 | 0.57 | 2.95 | 3.05 |
| Low Estimate | 0.62 | 0.48 | 2.77 | 2.63 |
| High Estimate | 0.81 | 0.62 | 3.11 | 3.24 |
| Year Ago EPS | 0.82 | 0.6 | 3.11 | 2.95 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 12 | 11 | 21 | 20 |
| Avg. Estimate | 14.43B | 13.54B | 62.93B | 63.03B |
| Low Estimate | 13.94B | 13.2B | 61.1B | 61.32B |
| High Estimate | 15.25B | 13.88B | 64.59B | 65.19B |
| Year Ago Sales | 14.88B | 13.28B | 63.63B | 62.93B |
| Sales Growth (year/est) | -3.04% | 1.92% | -1.09% | 0.15% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | 0.51 | 0.46 | 0.61 | 0.46 |
| EPS Actual | 0.82 | 0.6 | 1.06 | 0.63 |
| Difference | 0.31 | 0.14 | 0.45 | 0.17 |
| Surprise % | 60.11% | 30.19% | 73.28% | 37.20% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0.72 | 0.57 | 2.95 | 3.05 |
| 7 Days Ago | 0.71 | 0.57 | 2.95 | 3.05 |
| 30 Days Ago | 0.71 | 0.57 | 2.96 | 3.05 |
| 60 Days Ago | 0.72 | 0.6 | 2.93 | 3.04 |
| 90 Days Ago | 0.71 | 0.59 | 2.93 | 3.03 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | -- | -- | 2 |
| Up Last 30 Days | 1 | 1 | 2 | 2 |
| Down Last 7 Days | -- | 1 | 1 | 1 |
| Down Last 30 Days | -- | 1 | 2 | 4 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| PFE | -12.26% | -4.63% | -5.16% | 3.44% |
| S&P 500 | 16.20% | 6.69% | 10.00% | 14.33% |
Top Analysts Yahoo Finance’s Top Analysts section provides an objective scorecard to evaluate the accuracy of Wall Street analyst ratings and price targets.
Learn More
Yahoo Finance’s Top Analysts section provides an objective scorecard to evaluate the accuracy of Wall Street analyst ratings and price targets.
Learn MoreAnalyst | Overall Score | Direction Score | Price Score | Latest Rating | Price Target | Date |
|---|---|---|---|---|---|---|
| B of A Securities | 42 | 32 | 97 | Neutral | 29 | 2024-12-11 |
| BMO Capital | 42 | 41 | 77 | Outperform | 36 | 2024-05-02 |
| Cantor Fitzgerald | 42 | 29 | 99 | Overweight | 45 | 2024-10-25 |
| Truist Securities | 42 | 29 | 100 | Buy | 32 | 2024-12-18 |
| Citigroup | 41 | 35 | 87 | Neutral | 29 | 2025-01-29 |
| Morgan Stanley | 35 | 18 | 96 | Equal-Weight | 31 | 2024-10-31 |
| Guggenheim | 32 | 31 | 51 | Buy | - | 2025-03-18 |
| Wells Fargo | 31 | 9 | 100 | Equal-Weight | 30 | 2024-07-31 |
| UBS | 31 | 19 | 84 | Neutral | 28 | 2025-02-06 |
| Barclays | 30 | 13 | 86 | Equal-Weight | 32 | 2024-07-31 |
Rows per page
1-10 of 10
Upgrades & Downgrades
| Reiterates | Guggenheim: Buy to Buy | 3/18/2025 |
| Reiterates | Guggenheim: Buy to Buy | 3/12/2025 |
| Reiterates | Guggenheim: Buy to Buy | 2/10/2025 |
| Maintains | UBS: Neutral to Neutral | 2/5/2025 |
| Maintains | Citigroup: Neutral to Neutral | 1/28/2025 |
| Maintains | UBS: Neutral to Neutral | 1/8/2025 |
Related Tickers
MRK Merck & Co., Inc.
89.23
+1.86%
JNJ Johnson & Johnson
163.71
+0.36%
ABBV AbbVie Inc.
205.29
+1.27%
BMY Bristol-Myers Squibb Company
60.02
+1.90%
NVO Novo Nordisk A/S
69.30
-1.23%
LLY Eli Lilly and Company
822.51
+0.10%
GILD Gilead Sciences, Inc.
111.79
+0.57%
AMGN Amgen Inc.
306.95
+0.39%
GSK GSK plc
38.74
+0.57%
AZN AstraZeneca PLC
73.79
+1.30%